Highlights and Quick Summary
- Long-Term Investments for the quarter ending September 30, 2022 was $13 Million (a 0.0% decrease compared to previous quarter)
- Year-over-year quarterly Long-Term Investments decreased by 0.0%
- Annual Long-Term Investments for 2021 was $13 Million (a -13.33% decrease from previous year)
- Annual Long-Term Investments for 2020 was $15 Million (a 15.38% increase from previous year)
- Annual Long-Term Investments for 2019 was $13 Million (a 1200.0% increase from previous year)
Visit stockrow.com/BEAM
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical Long-Term Investments of Beam Therapeutics Inc.
Most recent Long-Term Investmentsof BEAM including historical data for past 10 years.Interactive Chart of Long-Term Investments of Beam Therapeutics Inc.
Beam Therapeutics Inc. Long-Term Investments for the past 10 Years (both Annual and Quarterly)
(All values are in $ million)
Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
---|---|---|---|---|---|
2022 | – | $13.0 | $13.0 | $13.0 | – |
2021 | $13.0 | $24.54 | $29.43 | $15.0 | $13.0 |
2020 | $15.0 | $15.0 | $13.33 | $13.33 | $15.0 |
2019 | – | – | – | $13.33 | $13.0 |
2018 | – | – | – | – | $1.0 |
2017 | – | – | – | – | $0.0 |
Business Profile of Beam Therapeutics Inc.
Sector: Healthcare
Industry: Biotechnology